Survivin-targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma.
第一作者:
Haisen,Yin
第一单位:
Department of Molecular Oncology, Eastern Hepatobiliary Surgical Hospital & National Center of Liver Cancer, Second Military Medical University, Shanghai, 200438, China; Department of Gastroenterology, Jingzhou Central Hospital & Clinical Medical College, Yangtze University, Jingzhou, 434023, Hubei Province, China.
作者:
医学主题词
生物碱类(Alkaloids);动物(Animals);癌, 肝细胞(Carcinoma, Hepatocellular);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);细胞存活(Cell Survival);Hep G2细胞(Hep G2 Cells);人类(Humans);肝肿瘤(Liver Neoplasms);小鼠(Mice);小鼠, 裸(Mice, Nude);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1016/j.canlet.2018.03.044
PMID
29608986
发布时间
2019-06-13
- 浏览12
Cancer letters
54-64页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



